Stocks of makers of biologic and “specialty” drugs plunged Monday after Democratic presidential frontrunner Hillary Clinton said she’ll soon release a plan to address “price gouging” in the industry. It was the one of the worst days of the year for the stock market performance of the biotech industry.
Are you up for a challenge?
